A Double-Blind Placebo-Controlled Study Evaluating the Onset of Action of Doxazosin Gastrointestinal Therapeutic System in the Treatment of Benign Prostatic Hyperplasia

DOX GITS significantly improved IPSS and Qmax by Day 3 of treatment, and these changes were maintained through Day 14. More patients receiving DOX GITS than placebo perceived improvement in symptoms as early as Day 1.